Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Intranasal administration of mesenchymal stem cells ameliorates the abnormal dopamine transmission system and inflammatory reaction in the R6/2 mouse model of huntington disease

: Yu-Taeger, Libo; Stricker-Shaver, Janice; Arnold, Katrin; Bambynek-Dziuk, Patrycja; Novati, Arianna; Singer, Elisabeth; Lourhmati, Ali; Fabian, Claire; Magg, Janine; Riess, Olaf; Schwab, Matthias; Stolzing, Alexandra; Danielyan, Lusine; Nguyen, Hoa Huu Phuc

Volltext ()

Cells 8 (2019), Nr.6, Art. 595, 22 S.
ISSN: 2073-4409
Zeitschriftenaufsatz, Elektronische Publikation
Fraunhofer IZI ()
Huntington's disease; cell therapy; mesenchymal stem cells; Intranasal; R6 / 2 mice; dopamine transmission; microglia; Neuroinflammation

Intrastriatal administration of mesenchymal stem cells (MSCs) has shown beneficial effects in rodent models of Huntington disease (HD). However, the invasive nature of surgical procedure and its potential to trigger the host immune response may limit its clinical use. Hence, we sought to evaluate the non-invasive intranasal administration (INA) of MSC delivery as an effective alternative route in HD. GFP-expressing MSCs derived from bone marrow were intranasally administered to 4-week-old R6/2 HD transgenic mice. MSCs were detected in the olfactory bulb, midbrain and striatum five days post-delivery. Compared to phosphate-buffered saline (PBS)-treated littermates, MSC-treated R6/2 mice showed an increased survival rate and attenuated circadian activity disruption assessed by locomotor activity. MSCs increased the protein expression of DARPP-32 and tyrosine hydroxylase (TH) and downregulated gene expression of inflammatory modulators in the brain 7.5 weeks after INA. While vehicle treated R6/2 mice displayed decreased Iba1 expression and altered microglial morphology in comparison to the wild type littermates, MSCs restored both, Iba1 level and the thickness of microglial processes in the striatum of R6/2 mice. Our results demonstrate significantly ameliorated phenotypes of R6/2 mice after MSCs administration via INA, suggesting this method as an effective delivering route of cells to the brain for HD therapy.